These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 25361080)
1. c-Abl antagonizes the YAP oncogenic function. Keshet R; Adler J; Ricardo Lax I; Shanzer M; Porat Z; Reuven N; Shaul Y Cell Death Differ; 2015 Jun; 22(6):935-45. PubMed ID: 25361080 [TBL] [Abstract][Full Text] [Related]
2. TEAD mediates YAP-dependent gene induction and growth control. Zhao B; Ye X; Yu J; Li L; Li W; Li S; Yu J; Lin JD; Wang CY; Chinnaiyan AM; Lai ZC; Guan KL Genes Dev; 2008 Jul; 22(14):1962-71. PubMed ID: 18579750 [TBL] [Abstract][Full Text] [Related]
3. Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition. Diepenbruck M; Waldmeier L; Ivanek R; Berninger P; Arnold P; van Nimwegen E; Christofori G J Cell Sci; 2014 Apr; 127(Pt 7):1523-36. PubMed ID: 24554433 [TBL] [Abstract][Full Text] [Related]
4. Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Zhao B; Kim J; Ye X; Lai ZC; Guan KL Cancer Res; 2009 Feb; 69(3):1089-98. PubMed ID: 19141641 [TBL] [Abstract][Full Text] [Related]
5. Serum Inter-α-inhibitor activates the Yes tyrosine kinase and YAP/TEAD transcriptional complex in mouse embryonic stem cells. Pijuan-Galitó S; Tamm C; Annerén C J Biol Chem; 2014 Nov; 289(48):33492-502. PubMed ID: 25301940 [TBL] [Abstract][Full Text] [Related]
6. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity. Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865 [TBL] [Abstract][Full Text] [Related]
7. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides. Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421 [TBL] [Abstract][Full Text] [Related]
8. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Lamar JM; Stern P; Liu H; Schindler JW; Jiang ZG; Hynes RO Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2441-50. PubMed ID: 22891335 [TBL] [Abstract][Full Text] [Related]
9. Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD. Mesrouze Y; Bokhovchuk F; Meyerhofer M; Fontana P; Zimmermann C; Martin T; Delaunay C; Erdmann D; Schmelzle T; Chène P Elife; 2017 Apr; 6():. PubMed ID: 28430104 [TBL] [Abstract][Full Text] [Related]
10. YAP/TEAD-mediated transcription controls cellular senescence. Xie Q; Chen J; Feng H; Peng S; Adams U; Bai Y; Huang L; Li J; Huang J; Meng S; Yuan Z Cancer Res; 2013 Jun; 73(12):3615-24. PubMed ID: 23576552 [TBL] [Abstract][Full Text] [Related]
11. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Levy D; Adamovich Y; Reuven N; Shaul Y Mol Cell; 2008 Feb; 29(3):350-61. PubMed ID: 18280240 [TBL] [Abstract][Full Text] [Related]
12. Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling. Liang Z; Wang Y; Shen Z; Teng X; Li X; Li C; Wu W; Zhou Z; Wang Z Tumour Biol; 2016 Aug; 37(8):10909-15. PubMed ID: 26886283 [TBL] [Abstract][Full Text] [Related]
13. Structural insights into the YAP and TEAD complex. Li Z; Zhao B; Wang P; Chen F; Dong Z; Yang H; Guan KL; Xu Y Genes Dev; 2010 Feb; 24(3):235-40. PubMed ID: 20123905 [TBL] [Abstract][Full Text] [Related]
14. Identification of mechanism that couples multisite phosphorylation of Yes-associated protein (YAP) with transcriptional coactivation and regulation of apoptosis. Lee KK; Yonehara S J Biol Chem; 2012 Mar; 287(12):9568-78. PubMed ID: 22308035 [TBL] [Abstract][Full Text] [Related]
15. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202 [TBL] [Abstract][Full Text] [Related]
16. Targeting YAP in malignant pleural mesothelioma. Zhang WQ; Dai YY; Hsu PC; Wang H; Cheng L; Yang YL; Wang YC; Xu ZD; Liu S; Chan G; Hu B; Li H; Jablons DM; You L J Cell Mol Med; 2017 Nov; 21(11):2663-2676. PubMed ID: 28470935 [TBL] [Abstract][Full Text] [Related]
17. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Mo JS; Meng Z; Kim YC; Park HW; Hansen CG; Kim S; Lim DS; Guan KL Nat Cell Biol; 2015 Apr; 17(4):500-10. PubMed ID: 25751140 [TBL] [Abstract][Full Text] [Related]
18. Mutual dependence of the MRTF-SRF and YAP-TEAD pathways in cancer-associated fibroblasts is indirect and mediated by cytoskeletal dynamics. Foster CT; Gualdrini F; Treisman R Genes Dev; 2017 Dec; 31(23-24):2361-2375. PubMed ID: 29317486 [TBL] [Abstract][Full Text] [Related]
19. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3. Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596 [TBL] [Abstract][Full Text] [Related]
20. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Liu-Chittenden Y; Huang B; Shim JS; Chen Q; Lee SJ; Anders RA; Liu JO; Pan D Genes Dev; 2012 Jun; 26(12):1300-5. PubMed ID: 22677547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]